246 related articles for article (PubMed ID: 21953616)
1. A phase and frequency alignment protocol for 1H MRSI data of the prostate.
Wright AJ; Buydens LM; Heerschap A
NMR Biomed; 2012 May; 25(5):755-65. PubMed ID: 21953616
[TBL] [Abstract][Full Text] [Related]
2. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis.
Pels P; Ozturk-Isik E; Swanson MG; Vanhamme L; Kurhanewicz J; Nelson SJ; Van Huffel S
NMR Biomed; 2006 Apr; 19(2):188-97. PubMed ID: 16411280
[TBL] [Abstract][Full Text] [Related]
3. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification.
Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A
PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096
[TBL] [Abstract][Full Text] [Related]
4. Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe.
Arteaga de Castro CS; Boer VO; Luttje MP; van der Velden TA; Bhogal A; van Vulpen M; Luijten PR; van der Heide UA; Klomp DW
NMR Biomed; 2014 Nov; 27(11):1353-60. PubMed ID: 25212868
[TBL] [Abstract][Full Text] [Related]
5. Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer.
Zechmann CM; Menze BH; Kelm BM; Zamecnik P; Ikinger U; Giesel FL; Thieke C; Delorme S; Hamprecht FA; Bachert P
Acad Radiol; 2012 Jun; 19(6):675-84. PubMed ID: 22578226
[TBL] [Abstract][Full Text] [Related]
6. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence.
Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB
Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699
[TBL] [Abstract][Full Text] [Related]
7. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
[TBL] [Abstract][Full Text] [Related]
8. Effect of gold marker seeds on magnetic resonance spectroscopy of the prostate.
Hossain M; Schirmer T; Richardson T; Chen L; Buyyounouski MK; Ma CM
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):451-8. PubMed ID: 22245188
[TBL] [Abstract][Full Text] [Related]
9. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
[TBL] [Abstract][Full Text] [Related]
11. Metabolite ratios in 1H MR spectroscopic imaging of the prostate.
Kobus T; Wright AJ; Weiland E; Heerschap A; Scheenen TW
Magn Reson Med; 2015 Jan; 73(1):1-12. PubMed ID: 24488656
[TBL] [Abstract][Full Text] [Related]
12. Reduced power magnetic resonance spectroscopic imaging of the prostate at 4.0 Tesla.
Near J; Romagnoli C; Bartha R
Magn Reson Med; 2009 Feb; 61(2):273-81. PubMed ID: 19165876
[TBL] [Abstract][Full Text] [Related]
13. Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
Créhange G; Parfait S; Liegard M; Maingon P; Ben Salem D; Cochet A; Funes de la Vega M; Cormier L; Bonnetain F; Mirjolet C; Brunotte F; Walker PM
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1087-94. PubMed ID: 20615624
[TBL] [Abstract][Full Text] [Related]
14. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
[TBL] [Abstract][Full Text] [Related]
15. Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score.
Selnaes KM; Gribbestad IS; Bertilsson H; Wright A; Angelsen A; Heerschap A; Tessem MB
NMR Biomed; 2013 May; 26(5):600-6. PubMed ID: 23280546
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.
Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW
J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013
[TBL] [Abstract][Full Text] [Related]
17. Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching.
Scheidler J; Vogel M; Gross P; Heuck A
Rofo; 2009 Jun; 181(6):531-5. PubMed ID: 19353482
[TBL] [Abstract][Full Text] [Related]
18. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
19. Short echo time in vivo prostate ¹H-MRSI.
Venugopal N; McCurdy B; Al Mehairi S; Alamri A; Sandhu GS; Sivalingam S; Drachenberg D; Ryner L
Magn Reson Imaging; 2012 Feb; 30(2):195-204. PubMed ID: 22154684
[TBL] [Abstract][Full Text] [Related]
20. Spectrum separation resolves partial-volume effect of MRSI as demonstrated on brain tumor scans.
Su Y; Thakur SB; Karimi S; Du S; Sajda P; Huang W; Parra LC
NMR Biomed; 2008 Nov; 21(10):1030-42. PubMed ID: 18759383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]